Straumann Holding AG Long-Term Investments 2012-2021 | SAUHY

Straumann Holding AG long-term investments from 2012 to 2021. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Straumann Holding AG long-term investments for the quarter ending December 31, 2021 were $0.142B, a 1.82% decline year-over-year.
  • Straumann Holding AG long-term investments for 2021 were $0.142B, a 10.9% increase from 2020.
  • Straumann Holding AG long-term investments for 2020 were $0.128B, a 3.3% increase from 2019.
  • Straumann Holding AG long-term investments for 2019 were $0.124B, a 14.3% decline from 2018.
Straumann Holding AG Annual Long-Term Investments
(Millions of US $)
2021 $142
2020 $128
2019 $124
2018 $144
2017 $94
2016 $113
2015 $107
2014 $345
2013 $296
2012 $266
2011 $17
Straumann Holding AG Quarterly Long-Term Investments
(Millions of US $)
2021-12-31 $142
2020-12-31 $128
2020-06-30 $111
2019-12-31 $124
2018-12-31 $144
2017-12-31 $94
2017-06-30 $78
2016-12-31 $113
2016-06-30 $118
2015-12-31 $107
2014-12-31 $345
2013-12-31 $296
2013-06-30 $266
2012-12-31 $266
2012-06-30 $283
2011-12-31 $17
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.137B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09